Detalhe da pesquisa
1.
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.
N Engl J Med
; 371(20): 1877-88, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25265492
2.
Cu and Zn promoted Al-fumarate metal organic frameworks for electrocatalytic CO2 reduction.
RSC Adv
; 14(5): 3489-3497, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38259983
3.
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Lancet Oncol
; 13(8): 773-81, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22805291
4.
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.
Lancet Oncol
; 13(8): 782-9, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22805292
5.
Molecular Identification and Evaluation of the Genetic Diversity of Dendrobium Species Collected in Southern Vietnam.
Biology (Basel)
; 9(4)2020 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32290139
6.
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.
J Clin Oncol
; 37(11): 912-922, 2019 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30742566
7.
A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors.
Clin Cancer Res
; 21(4): 730-8, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25500057
8.
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.
Eur J Cancer
; 50(12): 2072-81, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24915778
9.
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours.
Eur J Cancer
; 49(9): 2077-85, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583440
10.
Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor.
J Clin Oncol
; 31(4): 482-9, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23248257
11.
Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors.
Clin Cancer Res
; 16(11): 3044-56, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20501621
12.
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
J Clin Oncol
; 27(21): 3557-65, 2009 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19546406
13.
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.
Blood
; 109(7): 3115-23, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17148592